AminoChain focuses on tokenizing stem cells, a form of regenerative therapy, and creating incentives for donors to participate.
AminoChain has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
AminoChain's investors include Antler, Plug and Play, Alumni Ventures, a16z crypto, Rosecliff Ventures.
AminoChain is headquartered in New York, United States.
AminoChain focuses on tokenizing stem cells, a form of regenerative therapy, and creating incentives for donors to participate.
AminoChain is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AminoChain — Funding & Investors." VCBacked, September 25, 2024, https://www.vcbacked.co/company/aminochain. Accessed September 29, 2026.
VCBacked. (2024). AminoChain — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/aminochain
{{cite web |title=AminoChain — Funding & Investors |url=https://www.vcbacked.co/company/aminochain |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated